One Size Does Not Always Fit All in Value Assessment
Laying a clear path for incorporating reliable evidence on heterogeneity in value assessments could improve their applicability for healthcare decision making.
Impact of a Value-Based Formulary in Three Chronic Disease Cohorts
A value-based formulary was implemented that used cost-effectiveness analysis to inform medication co-payments. Diabetes cohort expenditures decreased by $9 per member per month.
2 Clarke Drive Cranbury, NJ 08512